Modulating Repetitive Negative Thinking Related Brain Networks in Young Adults With Depression
| 対象疾患 | Depressive Disorder, Major |
|---|---|
| 相 | 該当なし |
| スポンサー | Laureate Institute for Brain Research, Inc. |
| ステータス | 早期終了 |
| 参加者数 | 54 名 |
| 介入（薬剤） | Active neurofeedback, Sham neurofeedback |
| 開始日 | 2024年1月12日 |
| 完了日 | 2025年4月4日 |
| 結果公開日 | 2026年6月17日 |
概要
In this project, the investigators use real-time fMRI neurofeedback (rtfMRI-nf) to causally relate dysfunction of right anterior insula (rAI) and right superior temporal sulcus (rSTS) connectivity with the intensity of repetitive negative thinking (RNT). The investigators hypothesize that rtfMRI-nf reducing rAI-rSTS connectivity would reduce RNT. The investigators propose a randomized double-blind, sham-controlled trial of rtfMRI-nf with 110 young adults (n=55/arm) with major depressive disorder (MDD) and high trait-RNT levels.
Functional Connectivity Change Between Right Anterior Insular (rAI) and Right Superior Temporal Sulcus (rSTS) Within Visit1
| Active Neurofeedback | -0.1140 ± 0.0731 beta-value |
|---|---|
| Sham Neurofeedback | 0.5553 ± 0.1594 beta-value |
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- CBT+ for Depression — University of Wisconsin, Madison
- Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neu — Stanford University
- Severe Asthma, MepolizumaB and Affect: SAMBA Study — University Hospital Southampton NHS Foundation Trust
- Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for — Levomecor Inc.
- A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major De — Levomecor Inc.
- Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders — Massachusetts General Hospital